S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|CF Industries, Yara call off merger talks (2014/10/17)|
|Vertex Announces Upcoming Presentations of Data at North American Cystic Fibrosis Conference - October 9 to 11, 2014|
|Vertex Receives European Approval for KALYDECO™ (ivacaftor) in Eight Non-G551D Gating Mutations|
|AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program|
|Vertex Reviews Recent Progress and Announces Upcoming Milestones in the Development of Multiple Combinations of Medicines that Target the Underlying Cause of Cystic Fibrosis|
|FDA Advisory Committee Recommends Approval of KALYDECO® (ivacaftor) for Use in People with Cystic Fibrosis Ages 6 and Older Who Have the R117H Mutation|
|CF Industries Holdings, Inc. Reports Second Quarter Net Earnings of $312.6 Million (2014/8/6)|
|Yara Chief Resigns Amid Merger Talks (2014/10/7)|
|Yara Chief Executive Officer Resigns Amid Merger Talks (2014/10/7)|
|Norsk Hydro CEO Declines Yara Top Job (2014/9/26)|
Click above to view more mutual fund data and stats for 8229 - CFS Corporation.